V-Square Quantitative Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
AIM
SLAM
CWP
V-Square Quantitative Management's PFE Position: Q2 2026 in Review
V-Square Quantitative Management reduced its Pfizer (PFE) stake by 37% in Q2 2026, selling an estimated $572K and leaving 37,806 shares worth $910K. The position accounts for 0.09% of the portfolio, ranked #203.
V-Square Quantitative Management first reported a position in PFE in Q2 2023 and has held it in 13 quarters since. The position peaked at $1.81M in Q3 2025. 1,189 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- V-Square Quantitative Management held 37,806 shares of Pfizer worth $910K as of Q2 2026.
- V-Square Quantitative Management sold 21,876 Pfizer shares in Q2 2026, an estimated $572K.
- Pfizer made up 0.09% of V-Square Quantitative Management's portfolio in Q2 2026, its #203 holding.
- V-Square Quantitative Management first reported a position in Pfizer in Q2 2023 and has held it in 13 quarters since.
- V-Square Quantitative Management's Pfizer position peaked at $1.81M in Q3 2025.
- 1,189 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on V-Square Quantitative Management's 13F filing for Q2 2026, filed 27 Jul 2026.